Wego’s interventional equipment subsidiary has secured a nine-digit dollar amount from a host of investors including China Construction Bank’s CCB International vehicle.
Shandong Wego Interventional Medical Technology, a subsidiary of China-based medical device manufacturer Wego, secured billions of yuan (RMB1bn = $157m) in series A funding yesterday.
XJ Capital, an investment manager sponsored by investment banking firm Citic Group, invested $66m to lead the round, which included financial services firm China Construction Bank’s CCB International unit, Haitong-Fortis Yangtze River Growth Equity Investment, China-Belgium Direct Equity Investment Fund and unnamed others.
Formed in 2013, Wego Interventional produces interventional equipment and consumables intended for…
